CClinicalTrials.gg
CompletedNCT05404776Updated Aug 6, 2025Results posted

Tension Versus Tension- Free Foley Balloon for Cervical Ripening

An interventional study of Placement of Foley balloon for cervical ripening with tension. and Placement of Foley balloon for cervical ripening without tension. in Induced Vaginal Delivery, sponsored by The University of Texas Medical Branch, Galveston. Completed at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-06.

Sponsored by The University of Texas Medical Branch, Galveston · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
279
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

Foley balloons are commonly used as a mechanical method of cervical ripening for induction of labor. Foley balloons may be placed either under tension or without tension (tension-free). The purpose of our study is to examine time to delivery in nulliparous women undergoing induction of labor who have a Foley balloon placed as a mechanical cervical dilator, assigned to either tension or without tension. The goal is to determine if there is a potential added benefit to placing the Foley balloon on tension as compared to no tension. Our hypothesis is that Foley balloon under tension for cervical ripening results in shorter time to vaginal delivery compared to Foley balloon placed without tension.

Read the detailed description

This is a pragmatic cluster randomized clinical trial. The target population is nulliparous women who present for induction of labor at term. If there is a decision by the obstetric team to place a transcervical Foley dilator for cervical ripening in a prospective subject meeting inclusion criteria for the study, the obstetric provider will follow the weekly randomization sequence for study group (No Tension) or the control group (Tension) based on the assigned cluster for the entire unit for that week. Both study groups will receive standardized labor management as Foley balloon placed with tension and without tension are both considered standard of care at our institution.

The Tension standard of care (control group) will undergo induction of labor by placement of a transcervical Foley balloon, which is standard of care at our institution. The balloon tubing will be pulled to create tension and will then be taped to the patient's inner thigh.

The No Tension standard of care (study group) will undergo induction of labor by placement of a transcervical Foley balloon. The balloon tubing will be left free of tension and will hang freely.

Subjects in the control and study group will then undergo standard intrapartum care. The total participation time in the study will be considered terminated following delivery.

02

Conditions studied

  • Induced Vaginal Delivery

Keywords

  • Induced Vaginal Delivery
  • Cervical Ripening
  • Mechanical Cervical Ripening
03

In context

Lead sponsor

The University of Texas Medical Branch, Galveston is the lead sponsor of 251 studies on the registry; 38 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 25 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Term induction of labor
  • Nulliparous
  • Vertex
  • Singleton
  • Plan for Foley balloon placement by the managing obstetrics team
  • Cervical exam less than 3 cm dilated and less than or equal to 60% effaced

Exclusion criteria

Exclusion Criteria:

  • Patient unwilling or unable to provide verbal consent
  • Fetal demise or major congenital anomaly
  • Preterm (\<37 0/7weeks)
  • Multiple gestation
  • Previous uterine surgery
  • Abnormal placentation
  • Malpresentation
  • Magnesium infusion for preeclampsia with severe features
  • Prelabor rupture of membranes
  • Fetal growth restriction
  • Non-reassuring fetal heart rate tracing prior to inclusion
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
279 participants (actual)

Study arms

  • Experimental
    Without tension (tension free)

    The study group will undergo induction of labor by placement of a transcervical Foley balloon. The balloon tubing will be left free of tension and will hang freely.

    Other: Placement of Foley balloon for cervical ripening without tension.

  • Active comparator
    Tension

    The control group will undergo induction of labor by placement of a transcervical Foley balloon. The balloon tubing will be pulled to create tension and will then be taped to the patient's inner thigh.

    Other: Placement of Foley balloon for cervical ripening with tension.

Interventions

  • OtherPlacement of Foley balloon for cervical ripening with tension.

    A Foley balloon will be placed for cervical ripening with tension.

  • OtherPlacement of Foley balloon for cervical ripening without tension.

    A Foley balloon will be placed for cervical ripening without tension.

06

What researchers measure

Primary outcomes

  1. Time to Vaginal Delivery

    Time to vaginal delivery measured from time of initial Foley balloon placement to delivery

    Time frame: Foley bulb placement to vaginal delivery, up to 24 Hours

Secondary outcomes

  1. Number of Participants That Requested Analgesia Following Placement of the Foley Balloon

    Request for IV pain medications or epidural following placement of Foley balloon

    Time frame: Placement of Foley balloon until removal of Foley balloon in minutes (up to 12 hours)

  2. Number of Participants That Had a Primary Cesarean Delivery

    Number of participants that had a primary cesarean delivery

    Time frame: Placement of Foley balloon until cesarean delivery, up to 24 Hours

  3. Number of Participants With Chorioamnionitis

    Number of participants with chorioamnionitis

    Time frame: Placement of Foley balloon until delivery, up to 24 Hours

Other outcomes

  1. Number of Participants With Postpartum Hemorrhage

    Number of participants with postpartum hemorrhage

    Time frame: Placement of Foley balloon until 24 hours postpartum

07

Results

Posted Aug 6, 2025

Participant flow

Participant flow — Overall Study
MilestoneWithout Tension (Tension Free)Tension
Started141138
Completed141138
Not completed00

Outcome measures

PrimaryTime to Vaginal Delivery

Time to vaginal delivery measured from time of initial Foley balloon placement to delivery

Time frame:
Foley bulb placement to vaginal delivery, up to 24 Hours
Reported as:
Median · minutes
Time to Vaginal Delivery
minutesWithout Tension (Tension Free)Tension
Time to Vaginal Delivery1608 (430 to 3438)1595.5 (507 to 3323)
SecondaryNumber of Participants That Requested Analgesia Following Placement of the Foley Balloon

Request for IV pain medications or epidural following placement of Foley balloon

Time frame:
Placement of Foley balloon until removal of Foley balloon in minutes (up to 12 hours)
Reported as:
Count of participants · Participants
Number of Participants That Requested Analgesia Following Placement of the Foley Balloon
ParticipantsWithout Tension (Tension Free)Tension
Number of Participants That Requested Analgesia Following Placement of the Foley Balloon119114
SecondaryNumber of Participants That Had a Primary Cesarean Delivery

Number of participants that had a primary cesarean delivery

Time frame:
Placement of Foley balloon until cesarean delivery, up to 24 Hours
Reported as:
Count of participants · Participants
Number of Participants That Had a Primary Cesarean Delivery
ParticipantsWithout Tension (Tension Free)Tension
Number of Participants That Had a Primary Cesarean Delivery4247
SecondaryNumber of Participants With Chorioamnionitis

Number of participants with chorioamnionitis

Time frame:
Placement of Foley balloon until delivery, up to 24 Hours
Reported as:
Count of participants · Participants
Number of Participants With Chorioamnionitis
ParticipantsWithout Tension (Tension Free)Tension
Number of Participants With Chorioamnionitis4048
Other pre-specifiedNumber of Participants With Postpartum Hemorrhage

Number of participants with postpartum hemorrhage

Time frame:
Placement of Foley balloon until 24 hours postpartum

No measurements were reported for this outcome.

Adverse events

Collected over 6 months. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Without Tension (Tension Free)0/141 (0%)0/141 (0%)0/141 (0%)
Tension0/138 (0%)0/138 (0%)0/138 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Without Tension (Tension Free)TensionTotal
Median23 (18 to 39)22 (18 to 42)22 (18 to 42)
Sex: Female, Male
Sex: Female, Male(Participants)Without Tension (Tension Free)TensionTotal
Female141138279
Male000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Without Tension (Tension Free)TensionTotal
Hispanic or Latino9488182
Not Hispanic or Latino475097
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Without Tension (Tension Free)TensionTotal
American Indian or Alaska Native213
Asian404
Native Hawaiian or Other Pacific Islander000
Black or African American201434
White115122237
More than one race000
Unknown or Not Reported011
Region of Enrollment
Region of Enrollment(Participants)Without Tension (Tension Free)TensionTotal
United States141138279
08

Study locations

1 site
  • University of Texas Medical Branch
    Galveston, Texas 77555, United States
09

References and documents

Publications

  • Adhikari EH, Nelson DB, McIntire DD, Leveno KJ. Foley Bulb Added to an Oral Misoprostol Induction Protocol: A Cluster Randomized Trial. Obstet Gynecol. 2020 Nov;136(5):953-961. doi: 10.1097/AOG.0000000000004123. PubMed 33030881 ↗
  • Connolly KA, Kohari KS, Factor SH, Rekawek P, Miller MR, Smilen BS, Stone JL, Bianco AT. A Randomized Trial of Foley Balloon Induction of Labor Trial in Multiparas (FIAT-M). Am J Perinatol. 2017 Sep;34(11):1108-1114. doi: 10.1055/s-0037-1603994. Epub 2017 Jun 26. No abstract available. PubMed 28651258 ↗
  • Connolly KA, Kohari KS, Rekawek P, Smilen BS, Miller MR, Moshier E, Factor SH, Stone JL, Bianco AT. A randomized trial of Foley balloon induction of labor trial in nulliparas (FIAT-N). Am J Obstet Gynecol. 2016 Sep;215(3):392.e1-6. doi: 10.1016/j.ajog.2016.03.034. Epub 2016 Mar 24. PubMed 27018464 ↗
  • Fruhman G, Gavard JA, Amon E, Flick KV, Miller C, Gross GA. Tension compared to no tension on a Foley transcervical catheter for cervical ripening: a randomized controlled trial. Am J Obstet Gynecol. 2017 Jan;216(1):67.e1-67.e9. doi: 10.1016/j.ajog.2016.09.082. Epub 2016 Sep 15. PubMed 27640940 ↗
  • El Khouly NI. A prospective randomized trial comparing Foley catheter, oxytocin, and combination Foley catheter-oxytocin for labour induction with unfavourable cervix. J Obstet Gynaecol. 2017 Apr;37(3):309-314. doi: 10.1080/01443615.2016.1239075. Epub 2016 Dec 6. PubMed 27922285 ↗
  • Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N Engl J Med. 2018 Aug 9;379(6):513-523. doi: 10.1056/NEJMoa1800566. PubMed 30089070 ↗
  • Kuhlmann MJ, Spencer N, Garcia-Jasso C, Singh P, Abdelwahab M, Vaughn M, Marshall K, Prasad N, Soulsby-Monroy R, Saade GR, Saad AF. Foley Bulb Insertion by Blind Placement Compared With Direct Visualization: A Randomized Controlled Trial. Obstet Gynecol. 2021 Jan 1;137(1):139-145. doi: 10.1097/AOG.0000000000004182. PubMed 33278290 ↗
  • Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2016 Dec;128(6):1357-1364. doi: 10.1097/AOG.0000000000001778. PubMed 27824758 ↗
  • McMaster K, Sanchez-Ramos L, Kaunitz AM. Evaluation of a Transcervical Foley Catheter as a Source of Infection: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015 Sep;126(3):539-551. doi: 10.1097/AOG.0000000000001002. PubMed 26244535 ↗
  • Embrey MP, Mollison BG. The unfavourable cervix and induction of labour using a cervical balloon. J Obstet Gynaecol Br Commonw. 1967 Feb;74(1):44-8. doi: 10.1111/j.1471-0528.1967.tb03931.x. No abstract available. PubMed 6018096 ↗
  • Jozwiak M, Bloemenkamp KW, Kelly AJ, Mol BW, Irion O, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001233. doi: 10.1002/14651858.CD001233.pub2. PubMed 22419277 ↗
  • Schoen CN, Grant G, Berghella V, Hoffman MK, Sciscione A. Intracervical Foley Catheter With and Without Oxytocin for Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2017 Jun;129(6):1046-1053. doi: 10.1097/AOG.0000000000002032. PubMed 28486381 ↗
  • Pettker CM, Pocock SB, Smok DP, Lee SM, Devine PC. Transcervical Foley catheter with and without oxytocin for cervical ripening: a randomized controlled trial. Obstet Gynecol. 2008 Jun;111(6):1320-6. doi: 10.1097/AOG.0b013e31817615a0. PubMed 18515515 ↗
  • Benson M, Younes L, Watson A, Saade GR, Saad AF. Applying Tension to the Transcervical Foley Balloon and Delivery Times in Term Nulliparous Women Undergoing Induction of Labor: A Randomized Controlled Trial. Obstet Gynecol. 2024 May 1;143(5):670-676. doi: 10.1097/AOG.0000000000005546. Epub 2024 Feb 29. PubMed 38422505 ↗

Study documents

  • Protocol and statistical analysis plan · Feb 28, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Study records will be kept confidential as required by law. No IPD will be shared outside of UTMB. Identifiers will not be disclosed outside of the University of Texas Medical Branch (UTMB). The data collected will be kept on a password-secured UTMB computer. An encrypted USB flash drive will be used to transfer data. During analysis of the data, all identifiers will be deleted.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05404776
Lead sponsor
The University of Texas Medical Branch, Galveston
Responsible party
Sponsor
First posted
Jun 3, 2022
Start date
Jun 3, 2022
Primary completion
Jun 21, 2023
Completion
Jun 21, 2023
Results posted
Aug 6, 2025
Last update
Aug 6, 2025

Study contacts

Meagan V Benson, DO
principal investigator · University of Texas

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion